Catalyst Pharmaceuticals, Inc. (CPRX)
24.19
+0.08
(+0.33%)
USD |
NASDAQ |
Feb 24, 16:00
23.73
-0.46
(-1.90%)
After-Hours: 20:00
Catalyst Pharmaceuticals Shareholders Equity (Annual) : 727.63M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Ionis Pharmaceuticals, Inc. | 588.35M |
| Rigel Pharmaceuticals, Inc. | 3.288M |
| United Therapeutics Corp. | 6.444B |
| Karyopharm Therapeutics, Inc. | -292.93M |
| Krystal Biotech, Inc. | 1.220B |